Document Detail

Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
MedLine Citation:
PMID:  22330085     Owner:  NLM     Status:  Publisher    
Chronic granulomatous disease (CGD) is a rare immunodeficiency disorder in which phagocytic leukocytes fail to generate superoxide (O(2)(-)) and antimicrobial oxidants. The therapeutic validity of interferon-gamma (IFN-γ) has been well established in CGD patients but its underlying mechanisms remain poorly understood. One probable mechanism has been suggested to be modulation of nitric oxide (NO) release from phagocytic cells. Herein, we investigated NO production from neutrophil cells in CGD patients on treatment with IFN-γ in vivo and in vitro. We measured NO levels in sera from 19 CGD patients (group I: 7 patients treated with TMP-SMX, group II: 12 patients treated with TMP-SMX and IFN-γ simultaneously) and healthy control individuals (8 cases). We also measured NO production from neutrophils in both patients groups as well as in control group after adding 100U IFN-γ in vitro. Our results showed that there was a significant difference between the groups in the NO levels of serum; patients who received IFN-γ had significantly higher amount of NO than the other groups. Besides, NO levels increased significantly after adding 100U IFN-γ in vitro in three studied groups, considerably in the patients on treatment with IFN-γ. As a brief conclusion, the effect of IFN-γ in increasing NO production is obvious. This could be an explanation for the therapeutic effect of IFN-γ in patients with CGD as NO acts as a bactericidal agent and plays a role in host defense mechanism instead of O(2)(-).
Fariba Naderi Beni; Fatemeh Fattahi; Abbas Mirshafiey; Mohammad Ansari; Monireh Mohsenzadegan; Masoud Movahedi; Zahra Pourpak; Mostafa Moin
Related Documents :
1536665 - The radiographic criterion in the 1987 revised criteria for rheumatoid arthritis. reass...
6709715 - Ankle and subtalar motion during gait in arthritic patients.
18403245 - Mean platelet volume (mpv) as an inflammatory marker in ankylosing spondylitis and rheu...
18486765 - Type 1 diabetes risk for human leukocyte antigen (hla)-dr3 haplotypes depends on genoty...
21749185 - Autologous mesenchymal stem cells in chronic spinal cord injury.
21328055 - Receptor activator of nuclear factor kappa b ligand serum and synovial fluid level. a c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-11
Journal Detail:
Title:  International immunopharmacology     Volume:  -     ISSN:  1878-1705     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100965259     Medline TA:  Int Immunopharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier B.V. All rights reserved.
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical...
Next Document:  Inhibitory effects of an ellagic acid glucoside, okicamelliaside, on antigen-mediated degranulation ...